SRPT

Sarepta Therapeutics Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↑ 6/10
  • Value↓ 4/10
Sarepta Therapeutics sales and earnings growth
SRPT Growth
Good
  • Revenue Y/Y↓ -9.61%
  • EPS Y/Y↑ 123.90%
  • FCF Y/Y↑ 115.71%
Sarepta Therapeutics gross and profit margin trends
SRPT Profitability
Fair
  • Gross margin ↑ 62.90%
  • EPS margin↓ 3.00%
  • ROIC 5Y↓ -7.04%
Sarepta Therapeutics net debt vs free cash flow
SRPT Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↑ 5.2
  • Interest coverage↓ NA

Sarepta Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks